Consider for a moment the numerous activities the American Thyroid Association engages in. Besides the organization and programming of our annual meeting, we review and distribute research grants, commission and write practice guidelines, develop informational material for patients, engage with government leaders to advocate for evidence-based health policies, among many others. The ATA has a small and highly dedicated professional staff, but there is no question that the achievements of the ATA depend in large part on the pro bono efforts of our extraordinary members.

And of course, we have our three journals. Our flagship journal Thyroid has grown in stature under the outstanding leadership of Charles Emerson. His term is now coming to an end, and he deserves much credit and our gratitude for steering the journal to its present prominence. We are pleased to announce that, after an open search conducted by a committee led by Tony Hollenberg, the ATA accepted their recommendation to appoint Dr. Peter Kopp as the next Editor-in-Chief of Thyroid. Peter is a seasoned physician-scientist who has made many contributions to various areas of thyroidology, focusing in particular on germline defects that lead to various syndromes of thyroid dysfunction. He is also a practicing clinician, and is currently an Associate Editor of Thyroid. We are fortunate to have identified such a well-rounded scholar as the next Thyroid E-I-C, and wish him much success in his tenure.

In closing, and on behalf of our Secretary and Chief Operating Officer John Morris and our Executive Director Bobbi Smith, we want to salute all those of you who take leadership positions in the ATA: committee chairs, guidelines chairs, as well as those who put themselves forward for office in competitive elections. Having experienced the life of the ATA from within, we know the toll this takes on your incredibly busy schedules, which is a tribute to your devotion and investment in the advancement of the society, of the thyroid field and of the patients whose lives we seek to improve.

With best wishes,

James A. Fagin, MD
ATA President